Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)

Liver Cancer - Tập 7 Số 3 - Trang 235-260 - 2018
Jian Zhou1, Hui‐Chuan Sun1, Zheng Wang1, Wen‐Ming Cong2, Sheng Wang3, Mengsu Zeng4, Jia Yang5, Ping Bie6, Lian-xin Liu7, Tianfu Wen8, G. Han9, Maoqiang Wang10, Rui-Bao Liu11, Ligong Lu12, Zheng Ren1, Min-Shan Chen13, Zhao‐Chong Zeng14, Ping Liang15, Changhong Liang16, Min Chen17, Fuhua Yan18, Wen Ping Wang19, Yuan Ji20, Wen-Wu Cheng21, Chenyun Dai22, Wei-Dong Jia23, Ya-Ming Li24, Ye‐Xiong Li25, Jun Liang26, Tian Shu Liu27, Guoyue Lv28, Yongyang Mao29, Wei Ren30, Hong Shi31, Wen Tao Wang8, Xiaoying Wang1, Bao-Cai Xing32, Jian-Ming Xu33, Jian-Yong Yang34, Ye Yang35, Sheng-Long Ye1, Zheng-Yu Yin36, Bo-Heng Zhang1, Shui-Jun Zhang37, Wei Zhou5, Ji-Ye Zhu38, Rong Liu3, Ying-Hong Shi1, Yong-sheng Xiao1, Gui‐Qi Zhu1, Gao‐Jun Teng39, Jian-qiang Cai40, Wei Lin Wang41, Jiahong Dong42, Qiang Li43, Feng Shen5, Shu-Kui Qin44, Jia Fan1
1Department of Liver Surgery & Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Fudan University, Shanghai, China
2Department of Pathology, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
3Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China
4Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, China
5Department of Hepatic Surgery, the Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
6Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University, Chongqing, China
7Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China
8Department of Liver Surgery, West China Hospital of Sichuan University, Chengdu, China
9Department of Liver Diseases and Digestive Interventional Radiology, Xijing Hospital, Fourth Military Medical University, Xi’an, China
10Department of Interventional Radiology, Chinese PLA General Hospital, Beijing, China
11Department of Interventional Radiology, The Tumor Hospital of Harbin Medical University, Harbin, China
12Department of Interventional Oncology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
13Department of Hepatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China
14Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
15Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing, China
16Department of Radiology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
17Editorial Department of Chinese Journal of Digestive Surgery, Chongqing, China
18Department of Radiology, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China
19Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, China
20Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China
21Department of integrated treatment, Tumor Hospital of Fudan University, Shanghai, China
22Department of Hepatobiliary and Spleenary Surgery, The Affiliated Shengjing Hospital, China Medical University, Shenyang, China
23Department of Hepatic Surgery, Affiliated Provincial Hospital, Anhui Medical University, Hefei, China
24Department of Nuclear Medicine, The First Hospital of China Medical University, Shenyang, China
25Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
26Department of Oncology, Peking University International Hospital, Beijing, China
27Department of Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
28Department of General Surgery, the First Hospital of Jilin University, Jilin, China
29Department of Liver Surgery, Peking Union Medical College (PUMC) Hospital, PUMC and Chinese Academy of Medical Sciences, Beijing, China
30Department of Interventional Radiology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
31Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, China
32Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital and Institute, Beijing, China
33Department of Gastrointestinal Oncology, Affiliated Hospital Cancer Center, Academy of Military Medical Sciences, Beijing, China
34Department of Interventional Oncology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
35Department of Hepatic Surgery and Interventional Radiology, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
36Department of Hepatobiliary Surgery, Zhongshan Hospital of Xiamen University, Xiamen, China
37Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
38Department of Hepatobiliary Surgery, Peking University People’s Hospital, Beijing, China
39Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, China
40Department of Abdominal Surgical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
41Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
42Department of Hepatobiliary and Pancreas Surgery, Beijing Tsinghua Changgung Hospital (BTCH), School of Clinical Medicine, Tsinghua University, Beijing, China
43Department of Hepatobiliary Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
44Department of Medical Oncology, PLA Cancer Center, Nanjing Bayi Hospital, Nanjing, China

Tóm tắt

<b><i>Background:</i></b> Hepatocellular carcinoma (HCC) (about 85–90% of primary liver cancer) is particularly prevalent in China because of the high prevalence of chronic hepatitis B infection. HCC is the fourth most common malignancy and the third leading cause of tumor-related deaths in China. It poses a significant threat to the life and health of Chinese people. <b><i>Summary:</i></b> This guideline presents official recommendations of the National Health and Family Planning Commission of the People’s Republic of China on the surveillance, diagnosis, staging, and treatment of HCC occurring in China. The guideline was written by more than 50 experts in the field of HCC in China (including liver surgeons, medical oncologists, hepatologists, interventional radiologists, and diagnostic radiologists) on the basis of recent evidence and expert opinions, balance of benefits and harms, cost-benefit strategies, and other clinical considerations. <b><i>Key Messages:</i></b> The guideline presents the Chinese staging system, and recommendations regarding patients with HCC in China to ensure optimum patient outcomes.

Từ khóa


Tài liệu tham khảo

10.3322/caac.21262

10.3322/caac.21338

10.1007/s00432-004-0552-0

10.1159/000367748

10.1016/S1499-3872(13)60096-X

10.1148/radiol.14140690

10.1097/RLI.0b013e3181caea5b

10.1245/s10434-013-3001-y

10.1007/s12072-013-9467-7

10.1159/000367750

10.1159/000367742

10.1007/s00330-015-3873-2

10.1007/s00259-014-2961-x

10.1007/s00259-009-1297-4

10.2967/jnumed.115.167338

10.2967/jnumed.108.055087

10.1016/j.ejrad.2011.08.004

10.2967/jnumed.108.057307

10.1148/rg.317115050

10.3413/Nukmed-0730-15-03

10.1002/hep.21966

10.1016/j.surg.2011.12.002

10.5858/arpa.2013-0691-RA

10.1245/s10434-011-1585-7

10.3748/wjg.v22.i42.9279

10.1016/0168-8278(91)90084-O

10.1245/s10434-012-2513-1

10.1007/s00268-010-0424-5

10.1016/j.humpath.2010.12.016

10.1097/TP.0000000000000489

10.1001/archsurg.138.11.1198

10.1053/jhep.1997.v26.pm0009362359

10.1016/S0016-5085(96)70070-7

10.1159/000346225

10.1097/SLA.0000000000001178

10.1016/j.jhep.2012.05.007

10.1038/srep07252

10.1097/01.sla.0000201480.65519.b8

10.1016/j.jhep.2014.03.012

10.1097/SLA.0000000000000382

10.1053/j.gastro.2008.02.091

10.1016/S1001-9294(15)30016-X

10.1007/BF00299771

10.1007/BF00316979

10.1007/BF02385702

10.4254/wjh.v8.i9.439

10.1002/bjs.5341

10.1245/s10434-015-5007-0

10.1097/SLA.0000000000001707

10.1097/00000658-200007000-00004

10.1016/j.ijsu.2015.05.009

10.1002/bjs.6841

10.1067/msy.2000.108659

10.1002/jso.23521

10.1097/SLA.0b013e3181961c16

10.1159/000480441

10.3748/wjg.v10.i19.2791

10.3748/wjg.v11.i8.1215

10.1002/hep.21415

10.1097/01.sla.0000245829.00977.45

10.1007/s00432-006-0091-y

10.1159/000082098

10.1056/NEJMoa0901282

10.1007/s00432-009-0584-6

10.1097/TP.0b013e31816b67e4

10.3748/wjg.15.4170

10.1016/j.jhep.2013.07.012

10.1002/lt.22441

10.1016/j.transproceed.2008.03.165

10.1245/s10434-014-3585-x

10.1111/j.1440-1746.2011.06947.x

10.1097/SLA.0b013e3181efc656

10.1200/JCO.2012.42.9936

10.1002/cncr.25314

10.1016/S0168-8278(98)80187-6

10.1007/s00270-013-0733-9

10.1002/hep.28453

10.1053/jhep.2002.33156

10.1016/S0140-6736(02)08649-X

10.1148/radiol.2241011262

10.1053/jhep.2003.50047

10.1007/s00432-013-1568-0

10.1016/j.jhep.2012.07.017

10.1007/s00270-009-9711-7

10.1038/bjc.2014.199

10.1111/jgh.13501

10.1159/000367757

10.1159/000367743

10.1097/00130404-200409000-0000810.1097/00130404-200409000-00008

10.1016/j.radonc.2008.11.002

10.1016/j.ijrobp.2004.05.025

10.1159/000367762

10.1016/j.ijrobp.2005.03.058

10.1186/1471-2407-14-878

10.1002/cncr.24300

10.1111/liv.12857

10.1016/j.ijrobp.2009.01.057

10.1016/S0360-3016(02)02846-8

10.1016/j.ijrobp.2005.12.031

10.1016/j.ijrobp.2010.07.1986

10.1093/jjco/hyv205

10.1118/1.4953190

10.2217/fon-2016-0035

10.1159/000343878

10.1002/hep.21465

10.1159/000481314

10.1056/NEJMoa0708857

10.1093/annonc/mds343

10.1200/JCO.2012.44.5643

10.1053/j.gastro.2015.02.055

10.1159/000449342

10.1080/2162402X.2015.1083671

10.1016/j.jnci.2013.03.005

10.3109/03009734.2012.729104

10.1158/1078-0432.CCR-09-1624

10.1200/JCO.2012.48.5896

10.1097/SLA.0000000000000858